Biogen and Samsung Bioepis to Present Data for Infliximab and Adalimumab Biosimilars at United European Gastroenterology Week

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to Biogen and Samsung Bioepis to Present Data for Infliximab and Adalimumab Biosimilars at United European Gastroenterology Week
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 198.58 +2.00 (1.02%)
Previous Close $196.58    52 Week High $333.65 
Open $199.48    52 Week Low $223.02 
Day High $200.98    P/E 25.43 
Day Low $194.74    EPS $7.81 
Volume 510,313